iLite® Functional Bioassays
The iLite® Functional Bioassay portfolio consists of cell lines provided in an “assay-ready” format for a rapid and convenient workflow. The assay-ready format also reduces assay variability, optimizing its use in screening, characterization, stability, and potency studies. iLite cell lines can be tailored to virtually any biopharmaceutical target.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The iLite Functional Bioassay portfolio is based on a reporter gene system and offers a convenient and powerful way of measuring and quantifying drug potency, detecting neutralizing antibodies (NAbs), and assessing immunogenicity.
The portfolio consists of:
Complement Products
iLite® C5a [BM4075]
Cytokine responsive
iLite® RANKL [BM4052]
iLite® TNF-alpha [BM3044]
iLite® Type I IFN [BM3049]
Hormone responsive
iLite® hCG [BM4080]
iLite® Insulin [BM3060]
Interleukine responsive
iLite® IL-2 [BM4002]
iLite® IL-6 [BM4061]
iLite® IL-12 [BM4012]
iLite® IL-23 [BM4023]
Growth Factors
iLite® VEGF [BM4021]
iLite® FGF-21 [BM3071]
iLite® GM-CSF [BM4050]
iLite® G-CSF [BM4055]
Toll-Like Receptors
iLite® TLR4 [BM4025]
iLite® TLR9 [BM6069]
Navigating the complexities of cell-based assays in GMP QC testing: The journey to robust assays
Deepen your understanding of cell-based assays and the process of developing robust cell-based assays for GMP QC testing in modern drug development
Biosimilar development: Experts discuss analytical characterization toolkits for antibody therapeutics
Experts from Xbrane Biopharma discuss the biosimilar development process and how bioassays are the driving force behind reduced cost and accelerated timelines
